Psychiatry and Neurology, Neurology · Sherman, TX
NPI
1396743720
Since 2005
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
321 N Highland Ave, Suite 200
Sherman, TX, 75092
Phone (903) 893-5141
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.6M
110,610 services
Medicare patients, 2024
794
Average age 72
Drug cost, 2024
$5.8M
5,589 prescriptions
Company payments, 2025
$4,048
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bharathy E Sundaram was code J2919 (injection, methylprednisolone sodium succinate, 5 mg), 33,125 times for 17 patients. In total Bharathy E Sundaram billed 110,610 services in 88 codes, and Medicare paid $1.6M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-01-31.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 33,125 | 17 | $0.22 | $7,391 |
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 20,528 | 39 | $4.59 | $94K |
| J0586 Injection, abobotulinumtoxina, 5 units | Office | 18,662 | 61 | $6.84 | $128K |
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 10,650 | 14 | $36.01 | $384K |
| 99214 Office E&M - Established | Office | 1,727 | 651 | $86.62 | $150K |
| J0587 Injection, rimabotulinumtoxinb, 100 units | Office | 1,565 | 16 | $10.21 | $16K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,053 | 530 | $11.68 | $12K |
| J0475 Injection, baclofen, 10 mg | Office | 363 | 25 | $131.31 | $48K |
| 99215 Office E&M - Established | Office | 274 | 222 | $125.49 | $34K |
| 96366 Intravenous Infusion, Hydration | Office | 240 | 20 | $14.96 | $3,591 |
| 64616 Musculoskeletal | Office | 185 | 62 | $127.33 | $24K |
| 96365 Intravenous Infusion, Hydration | Office | 157 | 21 | $46.02 | $7,225 |
| 95984 Electrical Nerve Conductivity | Office | 136 | 26 | $32.63 | $4,438 |
| 99205 Office E&M - New | Office | 103 | 103 | $152.64 | $16K |
| 64644 Musculoskeletal | Office | 97 | 37 | $113.13 | $11K |
By year: 2022 $2.2M for 84,607 services; 2023 $1.7M for 67,245 services; 2024 $1.6M for 110,610 services.
Medicare prescription drug claims, 2024
In 2024, the drug Bharathy E Sundaram prescribed most often to Medicare patients was Gabapentin, with 306 prescriptions and refills. In total Bharathy E Sundaram wrote 5,589 Medicare prescriptions that cost $5.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 306 | 431 | 68 | $6,001 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 281 | 484 | 80 | $5,630 |
| Clonazepam Generic | 212 | 238 | 39 | $3,826 |
| Memantine Hcl Generic | 185 | 325 | 46 | $6,040 |
| Baclofen Generic | 171 | 229 | 33 | $3,002 |
| Rytary Carbidopa/Levodopa | 139 | 229 | 32 | $141K |
| Tizanidine Hcl Generic | 138 | 213 | 40 | $2,109 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 133 | 183 | 27 | $5,065 |
| Lacosamide Generic | 131 | 170 | 20 | $23K |
| Primidone Generic | 111 | 186 | 23 | $4,070 |
| Donepezil Hcl Generic | 107 | 198 | 27 | $1,050 |
| Levetiracetam Generic | 103 | 221 | 28 | $4,219 |
| Pregabalin Generic | 103 | 117 | 19 | $1,098 |
| Amitriptyline Hcl Generic | 99 | 157 | 29 | $2,075 |
| Trazodone Hcl Generic | 96 | 162 | 22 | $613 |
Brand drugs: 1,173 claims; generic drugs: 4,416 claims; opioid claims: 191.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bharathy E Sundaram $4,048 ($4,048 in general payments such as food, travel and fees) from 28 companies. The largest payer was Genzyme Corporation with $2,147.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.